Key result
Nuclear medicine imaging, including PET and SPECT, detects early subclinical metabolic and perfusion changes in the myocardium following breast or thoracic radiotherapy.
Why the study?
Breast and thoracic irradiation can unintentionally expose the heart to radiation and cause cellular myocardial damage, making early detection and monitoring of radiation-induced heart disease crucial.
Does nuclear medicine imaging effectively detect early cardiotoxicity in patients undergoing breast or thoracic radiotherapy?
Systematic Review (n=939)
Does nuclear medicine imaging effectively detect early cardiotoxicity in patients undergoing breast or thoracic radiotherapy?
Nuclear medicine imaging can detect early subclinical metabolic and perfusion changes in the heart following breast or thoracic radiotherapy, which may help predict late cardiac complications.
May support earlier cardioprotection in radiotherapy patients; extends systematic evidence for PET/SPECT surveillance of subclinical cardiotoxicity.
Introduction: Radiotherapy has significantly improved cancer survival rates, but it also comes with certain unavoidable complications. Breast and thoracic irradiation, for instance, can unintentionally expose the heart to radiation, leading to damage at the cellular level within the myocardial structures. Detecting and monitoring radiation-induced heart disease early on is crucial, and several radionuclide imaging techniques have shown promise in this regard. Method: In this 10-year review, we aimed to identify nuclear medicine imaging modalities that can effectively detect early cardiotoxicity following radiation therapy. Through a systematic search on PubMed, we selected nineteen relevant studies based on predefined criteria. Results: The data suggest that incidental irradiation of the heart during breast or thoracic radiotherapy can cause early metabolic and perfusion changes. Nuclear imaging plays a prominent role in detecting these subclinical effects, which could potentially serve as predictors of late cardiac complications. Discussion: However, further studies with larger populations, longer follow-up periods, and specific heart dosimetric data are needed to better understand the relationship between early detection of cardiac abnormalities and radiation-induced heart disease.
No takes yet. Share an insight, caveat, or question.
Eber et al. (2023) conducted a systematic review in Radiation-induced cardiotoxicity (n=939). Nuclear medicine imaging (PET and SPECT) was evaluated on Early radiation-induced metabolic and perfusion changes. Nuclear medicine imaging, including PET and SPECT, detects early subclinical metabolic and perfusion changes in the myocardium following breast or thoracic radiotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: